TAILORED ANTICOAGULANT TREATMENT AFTER A FIRST VENOUS THROMBOEMBOLISM: PROTOCOL OF THE LEIDEN THROMBOSIS RECURRENCE RISK PREVENTION (L-TRRIP) STUDY - COHORT-BASED RANDOMISED CONTROLLED TRIAL

Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial

Introduction Patients with a first venous thromboembolism (VTE) are at risk of recurrence.Recurrent VTE (rVTE) can be prevented by extended anticoagulant therapy, but this comes at the cost of an increased risk of bleeding.It is still uncertain whether patients with an intermediate recurrence risk or with a high recurrence and high gold ps5 control

read more




Olefin dihydroxylation mediated by Os-Zn-Al hydrotalcite-like catalyst: The scope and reactivity using various co-oxidants

The heterogeneous oxidation of olefins to vicinal diols was investigated using an Os-Zn-Al hydrotalcite-like catalyst (HTlc).The Os-Zn-Al HTlc was synthesised by the co-precipitation method and characterised fully using XRD, FT-IR, TEM, SEM, ICP-OES and BET surface area measurements.The ability of the synthesised Os-Zn-Al HTlc to catalytically dihy

read more